D
Aquestive Therapeutics, Inc. AQST
$4.04 $0.133.33% NASDAQ
Recommendation
Prev Close
$3.85
Volume
90,485
Avg Vol (90D)
1,425,357
Market Cap
$465.75M
Dividend & Yield
--
52-Week Range
$2.12 - $5.80
P/E (TTM)
--
EPS (TTM)
-$0.6935
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Aquestive Therapeutics (AQST, $3.91) Aroon Indicator entered a Downtrend on August 21, 2025.
8/22/2025 - Tickeron - Stocks
Aquestive Therapeutics (AQST, $3.88) Aroon Indicator entered a Downtrend on August 20, 2025.
8/21/2025 - Tickeron - Stocks
Aquestive Therapeutics (AQST, $3.85) Aroon Indicator entered a Downtrend on August 19, 2025.
8/20/2025 - Tickeron - Stocks
Aquestive Therapeutics (AQST, $3.85) entered Downtrend as Momentum indicator drops below 0 level on Aug 19, 2025
8/20/2025 - Tickeron - Stocks
Cantor Fitzgerald Sticks to Their Buy Rating for Aquestive Therapeutics (AQST)
8/19/2025 - TipRanks Financial Blog
Aquestive Therapeutics (AQST, $4.18) Aroon Indicator entered a Downtrend on August 18, 2025.
8/19/2025 - Tickeron - Stocks
FY2025 EPS Estimates for AQST Increased by Cantor Fitzgerald
8/17/2025 - MarketBeat
Leerink Partnrs Has Positive Forecast for AQST Q3 Earnings
8/17/2025 - MarketBeat
Aquestive Therapeutics (AQST, $4.11) Aroon Indicator entered a Downtrend on August 15, 2025.
8/16/2025 - Tickeron - Stocks
The volume for Aquestive Therapeutics stock increased for one day, resulting in a record-breaking daily growth of 297% of the 65-Day Volume Moving Average
8/15/2025 - Tickeron - Stocks
Earnings Update: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Are Trimming Their Forecasts
8/14/2025 - Simply Wall St
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?
8/14/2025 - Zacks Investment Research
Aquestive Therapeutics Stock Is Rising Pre-Market Its $75M Funding Agreement Draws Divided Opinions From Retail
8/14/2025 - Stocktwits News Feed
Aquestive Therapeutics 21.25M share Secondary priced at $4.00
8/14/2025 - The Fly
Aquestive Therapeutics (AQST) Shares Surge on $85M Offering
8/14/2025 - GuruFocus
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock ...
8/14/2025 - GuruFocus
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
8/14/2025 - GuruFocus
Aquestive Therapeutics rises after pricing $85M stock offering
8/14/2025 - Seeking Alpha - Healthcare
Aquestive Therapeutics rises after pricing $85M stock offering
8/14/2025 - SeekingAlpha.com: All News
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
8/14/2025 - Globe Newswire
Aquestive Therapeutics announces $75M strategic funding agreement with RTW
8/14/2025 - The Fly
Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm (epinephrine) Sublingual Film
8/14/2025 - Globe Newswire
XTX Topco Ltd Takes $228,000 Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST)
8/14/2025 - MarketBeat
Aquestive Therapeutics (AQST) Gets a Buy from Lake Street
8/13/2025 - TipRanks Financial Blog
Aquestive Therapeutics (NASDAQ:AQST) Releases Earnings Results, Beats Expectations By $0.04 EPS
8/13/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
$44.13M
EBITDA (TTM)
-$51.99M
EBIT (TTM)
-$52.60M
Net Income (TTM)
-$65.04M
Balance Sheet
Total Assets (Q)
$93.70M
Total Debt (Q)
$40.26M
Total Liabilities (Q)
$166.29M
Book Value Per Share (Q)
-$0.7306
Cash Flow
Cash from Operations (TTM)
-$49.68M
Cash from Investing (TTM)
-$337.00K
Cash from Financing (TTM)
$20.69M
Net Change in Cash (TTM)
-$29.33M
Filings
Filing Date
Monday, August 11, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
1.09
7-Day Total Return
6.88%
30-Day Total Return
0.25%
60-Day Total Return
58.43%
90-Day Total Return
63.56%
Year to Date Total Return
10.08%
1-Year Total Return
-13.12%
2-Year Total Return
128.25%
3-Year Total Return
192.75%
5-Year Total Return
-50.79%
52-week Low
May 13, 2025 - $2.12
52-week High
Oct 30, 2024 - $5.80
Valuation
Market Cap
$465.75M - Small Cap
Enterprise Value
$445.47M
Price/Sales (TTM)
8.67
Price/Book (Q)
-5.27
Dividends and Shares
Shares Outstanding
99.33
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.aquestive.com
Phone Number
908 941 1900
Address
30 Technology Drive
Warren, NJ 07059
Country
United States
Year Founded
2004
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of... more
NASDAQ 08/22/2025 10:11AM Eastern Quotes delayed